These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 5337985)

  • 21. [Pharmacological susceptibility of cellular immunity].
    Floersheim GL
    Z Naturwiss Med Grundlagenforsch; 1965 Oct; 2(4):307-60. PubMed ID: 5887477
    [No Abstract]   [Full Text] [Related]  

  • 22. Inhibition of histamine-metabolizing enzymes and elevation of histamine levels in tissues by lipid-soluble anticancer folate antagonists.
    Duch DS; Edelstein MP; Nichol CA
    Mol Pharmacol; 1980 Jul; 18(1):100-4. PubMed ID: 6774226
    [No Abstract]   [Full Text] [Related]  

  • 23. Symposium on immunosuppressive drugs. Other clinical considerations.
    Murray JE; Austen KF
    Fed Proc; 1967; 26(3):953-7. PubMed ID: 5337289
    [No Abstract]   [Full Text] [Related]  

  • 24. A quinazoline antifolate as inhibitor of folate metabolism in mouse L-cells.
    Sikora E; Grzelakowska-Sztabert B
    Acta Biochim Pol; 1983; 30(2):193-201. PubMed ID: 6868908
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methotrexate preconditioning allows sufficient engraftment to confer drug resistance in mice transplanted with marrow expressing drug-resistant dihydrofolate reductase activity.
    Belur LR; James RI; May C; Diers MD; Swanson D; Gunther R; McIvor RS
    J Pharmacol Exp Ther; 2005 Aug; 314(2):668-74. PubMed ID: 15857949
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Symposium on immunosuppressive drugs. Some biochemical effects of alkylating agents.
    Wheeler GP
    Fed Proc; 1967; 26(3):885-92. PubMed ID: 5337282
    [No Abstract]   [Full Text] [Related]  

  • 27. Symposium on immunosuppressive drugs. Immunosuppressive drugs. I.
    Santos GW
    Fed Proc; 1967; 26(3):907-13. PubMed ID: 5337623
    [No Abstract]   [Full Text] [Related]  

  • 28. Gamma-glutamyl hydrolase and drug resistance.
    Schneider E; Ryan TJ
    Clin Chim Acta; 2006 Dec; 374(1-2):25-32. PubMed ID: 16859665
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The pharmacology of immunosuppressive agents.
    Mitchell MS; Bertino JR
    Conn Med; 1970 Dec; 34(12):843-50. PubMed ID: 4923392
    [No Abstract]   [Full Text] [Related]  

  • 30. Symposium on immunosuppressive drugs. Immunosuppressive drugs. II.
    Schwartz R
    Fed Proc; 1967; 26(3):914-7. PubMed ID: 5337284
    [No Abstract]   [Full Text] [Related]  

  • 31. An overview of folate metabolism: features relevant to the action and toxicities of antifolate anticancer agents.
    Calvert H
    Semin Oncol; 1999 Apr; 26(2 Suppl 6):3-10. PubMed ID: 10598549
    [No Abstract]   [Full Text] [Related]  

  • 32. Transfection studies to explore essential folate metabolism and antifolate drug synergy in the human malaria parasite Plasmodium falciparum.
    Wang P; Wang Q; Aspinall TV; Sims PF; Hyde JE
    Mol Microbiol; 2004 Mar; 51(5):1425-38. PubMed ID: 14982635
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modulation of both endogenous folates and thymidine enhance the therapeutic efficacy of thymidylate synthase inhibitors.
    van der Wilt CL; Backus HH; Smid K; Comijn L; Veerman G; Wouters D; Voorn DA; Priest DG; Bunni MA; Mitchell F; Jackman AL; Jansen G; Peters GJ
    Cancer Res; 2001 May; 61(9):3675-81. PubMed ID: 11325838
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Folate and antifolate pharmacology.
    Kamen B
    Semin Oncol; 1997 Oct; 24(5 Suppl 18):S18-30-S18-39. PubMed ID: 9420019
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biochemical pharmacology of lipophilic diaminopyrimidine antifolates in mouse and human cells in vitro.
    Greco WR; Hakala MT
    Mol Pharmacol; 1980 Nov; 18(3):521-8. PubMed ID: 6970329
    [No Abstract]   [Full Text] [Related]  

  • 36. Lack of impact of the loss of constitutive folate receptor alpha expression, achieved by RNA Interference, on the activity of the new generation antifolate pemetrexed in HeLa cells.
    Chattopadhyay S; Wang Y; Zhao R; Goldman ID
    Clin Cancer Res; 2004 Dec; 10(23):7986-93. PubMed ID: 15585634
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic activity of malononitrilamides (MNA 279 and MNA 715) on acute and chronic, relapsing, experimental, allergic encephalomyelitis (EAE).
    Schorlemmer HU; Bartlett RR
    Drugs Exp Clin Res; 1997; 23(5-6):175-81. PubMed ID: 9515227
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The molecular identity and characterization of a Proton-coupled Folate Transporter--PCFT; biological ramifications and impact on the activity of pemetrexed.
    Zhao R; Goldman ID
    Cancer Metastasis Rev; 2007 Mar; 26(1):129-39. PubMed ID: 17340171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Some considerations of folic acid antagonists.
    Scott CW
    Ala J Med Sci; 1971 Jan; 8(1):99-106. PubMed ID: 5578506
    [No Abstract]   [Full Text] [Related]  

  • 40. [Preparation and study of activity of heterologous antilymphocyte serums. (Preliminary research)].
    Nestoresco N; Popesco D; Strati I; Dima VF
    Arch Roum Pathol Exp Microbiol; 1968 Dec; 27(4):899-913. PubMed ID: 5742347
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.